Doctor's Prescription Now Mandatory for All Syrups in India

The Indian government has implemented a significant regulatory change, mandating a doctor's prescription for the purchase of all medicinal syrups, including commonly used cough syrups, effectively ending their over-the-counter (OTC) sale. This pivotal decision was formally announced through an amendment to the Drugs Rules, 1945, via the 'Drugs (Fifth Amendment) Rules, 2026', which came into force immediately upon its publication in the Official Gazette on June 9, 2026. The Union Ministry of Health and Family Welfare spearheaded this amendment, which specifically involves omitting the word "Syrups" from Schedule K, Serial No. 13, Entry 7, under the heading "Class of Drugs" of the Drugs Rules, 1945. Prior to this amendment, Schedule K provided exemptions for certain categories of drugs from specific provisions of the Drugs and Cosmetics Act, 1940, and its associated rules, allowing for easier public access to these medicines under certain conditions. The removal of "Syrups" from this exempted list means that all syrup-based formulations are now subject to stricter regulatory controls, requiring a valid prescription from a registered medical practitioner for their purchase. This comprehensive change affects a wide array of liquid oral medications that were previously available without a prescription, encompassing not only cough syrups but also other medicinal syrups. However, the impetus for this regulatory tightening has largely stemmed from growing concerns over drug safety, particularly in the wake of tragic incidents involving contaminated cough syrups. Several reports highlighted instances where tainted cough syrups were linked to the deaths of children in states like Madhya Pradesh and Rajasthan. Furthermore, global health alerts issued by the World Health Organisation (WHO) concerning India-made cough syrups further underscored the urgent need for enhanced oversight and stricter quality control measures in the manufacturing and distribution of such formulations. The government's decision is aimed at strengthening regulatory oversight of syrup formulations, ensuring quality monitoring, improving traceability, and preventing the misuse or indiscriminate consumption of these medicines. By requiring a doctor's prescription, the authorities intend to promote responsible distribution and sale practices, thereby enhancing patient safety across the country. This move also aligns with broader governmental efforts to regulate the use of cough and cold medications, especially among vulnerable populations such as young children. The National Formulary of India (NFI) 2026 had, in April of this year, cautioned against the use of cough suppressants in children under two years of age and highlighted the risks associated with the unmonitored use of such formulations. The amendment process included a public consultation phase. A draft notification outlining the proposed changes was initially published in December 2025. The Ministry of Health and Family Welfare invited objections and suggestions from various stakeholders and the general public. The government has confirmed that all comments and feedback received during this consultation period were thoroughly considered before the final rules were notified. The decision was also made in consultation with the Drugs Technical Advisory Board (DTAB), India's apex technical body for drug regulation, ensuring that the amendment is based on expert advice and public health considerations. While the amendment makes prescriptions mandatory for syrups, other forms of cough remedies, such as lozenges, pills, and tablets, that were previously exempted under Schedule K, will continue to be available over the counter. The immediate implementation of these new rules means that consumers will need to adjust their purchasing habits for these common medicines, and pharmacies nationwide are now required to comply with the revised regulations. This policy change marks a significant step towards greater control and safety in India's pharmaceutical sector for liquid oral medicines.

Frequently Asked Questions

Read Full Story on Quick Digest